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Abstract
Numerous Gram negative pathogens possess a type III secretion system (T3SS) which allows them to inject virulent proteins
directly into the eukaryotic cell cytoplasm. Injection of these proteins is dependent on a variable secretion signal sequence.
In this study, we utilized the N-terminal secretion signal sequence of Pseudomonas aeruginosa exotoxin ExoS to translocate
Cre recombinase containing a nuclear localization sequence (Cre-NLS). Transient exposure of human sarcoma cell line,
containing Cre-dependent lacZ reporter, resulted in efficient recombination in the host chromosome, indicating that the
bacterially delivered protein was not only efficiently localized to the nucleus but also retained its biological function. Using
this system, we also illustrate the ability of P. aeruginosa to infect mouse embryonic stem cells (mESC) and the susceptibility
of these cells to bacterially delivered Cre-NLS. A single two-hour infection caused as high as 30% of the mESC reporter cells
to undergo loxP mediated chromosomal DNA recombination. A simple antibiotic treatment completely eliminated the
bacterial cells following the delivery, while the use of an engineered mutant strain greatly reduced cytotoxicity. Utility of the
system was demonstrated by delivery of the Cre-NLS to induced pluripotent stem cells to excise the floxed oncogenic
nuclear reprogramming cassette. These results validate the use of T3SS for the delivery of transcription factors for the
purpose of cellular reprogramming.
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Introduction
Bacteria possess an arsenal of virulence factors used to moderate
eukaryotic cells. One such mechanism utilized by many Gram
negative bacteria is the type III secretion system (T3SS). This
transmembrane needle-like projection from the bacterial mem-
brane allows these pathogens to inject proteins across the
eukaryotic cell membrane, bypassing endocytic pathways [1],
[2]. While the type III secretion system itself is relatively conserved
among bacterial species, the secreted effectors have diverse
biological functions and typically modulate key host regulatory
proteins to promote bacterial infection [3]. The cytotoxic proteins
delivered by this system are guided to the injectisome by a variable
N-terminal signal sequence [4]–[7].
Pseudomonas aeruginosa is a ubiquitous opportunistic pathogen,
which secretes relatively few exotoxins by a single T3SS [3]. Type
III secretion is highly regulated in P. aeruginosa, and can be induced
in vitro by low extracellular calcium levels or direct host cell contact
[8], [9]. Once activated, P. aeruginosa secretes three of four
exotoxins: ExoS and ExoT, which possess both ADP ribosyl-
transferase and GTPase activating protein activity [10]; ExoY, an
adenylyl cyclase [11]; and ExoU, a lipase with hemolyic activity
[12], [13]. Ultimately, injection of these toxins results in host cell
rounding and death, rendering the bacterial survival advantage
within the host environment. Of these effectors, the functional
domains of ExoS are best characterized. Previous studies have
shown that various lengths of the N-terminus of ExoS can be fused
to exogenous proteins and direct them for injection into the host
cell cytosol in a type III secretion dependent manner [5], [6].
While one such study has demonstrated the functionality of these
injected fusion proteins by ex vivo complementation of a
cytoplasmic protein deficiency [6], the T3SS has not yet been
applied to the delivery of nuclear proteins.
The development of a simple, efficient system for introduction
of nuclear proteins would meet an emerging need which has been
made quite apparent in recent studies. The ability to reprogram
terminally differentiated nuclei to a pluripotent state by forced
expression of key transcription factors (Oct4, Sox2, cMyc, Klf4)
has been a remarkable breakthrough in molecular and cell biology
[14]–[16]. However, the therapeutic application of these repro-
grammed cells (iPS cells) is severely hindered by the integration of
oncogenic transgenes. There have been numerous attempts to
overcome this limitation, including the use of DNA reprogram-
ming cassettes which can be excised by Cre recombinase once cells
have been stably reprogrammed [17], [18]. Cre is a site specific,
bacteriophage derived recombinase which begets homologous
recombination between sequences known as LoxP sites [19]. A
DNA sequence flanked by direct repeat of LoxP sites will be
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is widely used in modern molecular biology and is particularly
useful in the generation of conditional gene knockouts [20].
In this report, we describe the use of the P. aeruginosa T3SS as an
alternative method to deliver functional Cre recombinase to the
nuclei of differentiated and pluripotent cells, achieving DNA
recombination through loxP sites on the chromosome, resulting in
alteration of host cell gene expression. Neither the transient
bacterial infection nor the bacterially delivered Cre affected the
pluripotency of the mouse ES cell or iPS cells. This study paves the
way for future application of this novel protein delivery technology
in therapeutic cellular reprogramming, as this is a safe alternative
to the current gene delivery mediated reprogramming method.
Results
Generation of a P. aeruginosa strain for protein delivery
The standard laboratory strain of P. aeruginosa (PAO1), whose
genome has been sequenced, secretes low levels of type III
effectors under type III inducing conditions. To identify a strain
with elevated type III secretion, we screened P. aeruginosa strains in
our collection, including commonly used laboratory strains as well
as clinical and environmental isolates. Interestingly, a laboratory
strain of PAK that had been passaged in our laboratory for over 10
years displayed the highest level of ExoS secretion under type III
inducing conditions (hereon referred to PAK-J) (Fig. 1A).
According to quantitative ELISA assays [9], this strain secretes
more than 10 times higher level of ExoS than the standard
laboratory strain PAK. As expected, infection of cultured
mammalian cells by this strain caused significantly higher
cytotoxicity, resulting in complete rounding and lifting of varius
adhering cells, such as HeLa and mouse embryonic fibroblast
(MEF), within 3 hours at an MOI of 20. Accounting for this, T3SS
injected bacterial effector protein ExoS can be detected in 100%
MEF cells under a similar infection condition, with injected ExoS
mainly localized around paranuclear region (Fig. 1B). The genetic
alterations in PAK-J that are responsible for elevated type III
secretion are actively being investigated.
The P. aeruginosa strain PAK-J expresses three type III secreted
effectors, ExoS, ExoT and ExoY, potent exotoxins that account
for much of the cytotoxicity associated with this bacterium. In
order to maximize protein injection, the delivery strain must be
capable of prolonged incubation with host cells. As such, each of
the three genes was deleted from the PAK-J chromosome by
Figure 1. Protein delivery by type III secretion system of P. aeruginosa. (A) Comparison of ExoS secretion by standard laboratory strains of
PAO1, PAK and a hyper secreting strain PAK-J. Strains were grown under type III secretion inducing conditions and culture supernatants were
subjected to Western blot analysis using anti-ExoS antibody which recognizes both ExoS and ExoT. (B) Immunohistochemistry of MEF cells following
infection by PAK-J (60 min at MOI 20). Cells were stained with anti-ExoS antibody followed by FITC labeled secondary antibody; (i) visualization of
ExoS; (ii) visualization of nuclei with Propidium Iodine stain; (iii) compilation of (i) & (ii). (C) Comparison of MEF viability after 3 hour infection with
PAK-J or PAK-JDSTY at indicated MOIs.
doi:10.1371/journal.pone.0016465.g001
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JDSTY, has comparatively reduced cytotoxicity, as assessed by the
number of adhered HeLa cells following the bacterial infections
(Fig. 1C). The assay results indicated that deletion of the PAK-J
type III secreted exotoxins reduces cytotoxicity by approximately
70%, which is consistent with the assay result of lactate
dehydrogenase release assay (data not shown). This diminution
in cytotoxicity will allow for increased infection duration, and thus
enhanced protein delivery by the type III secretion.
Following protein delivery, it is essential to completely eliminate
the residual bacterial cells to avoid contamination. Various
combinations of antibiotics were tested, including penicillin,
streptomycin, spectinomycin, gentamicin and ciprofloxacin. The
most effective combination was gentamicin with ciprofloxacin. In a
6-well plate, HeLa cells were infected with PAK-JDSTY at MOI
100 for 3 hours, freely floating bacterial cells were removed by
repeated washes with PBS, then the HeLa cells were grown in
DMEM+5% FBS supplemented with 200 ml/ml gentamicin and
20 ml/ml cirofloxacin. After 3 hours, majority bacterial cells were
killed with occasional recovery of 1–10 bacterial cells while no
viable bacterial cells were detected by 24 hours, as determined by
plating the whole HeLa cell lysates on L-agar plates. Further
confirming this, after the initial 24 hours of treatment with
antibiotics, the HeLa cells could be cultured in an antibiotic-free
medium for three days without bacterial contamination, demon-
strating effective elimination of the bacterial delivery cells. Most
importantly, neither the HeLa cell morphology nor its growth rate
has changed after subjecting to the bacterial infection and
clearance by antibiotics.
Injection of Cre recombinase through the bacterial T3SS
The bacteriophage derived Cre recombinase is a widely used
genetic tool which allows for excision of DNA between two LoxP
sequences by homologous recombination [19]. The Cre-Lox
system was chosen to demonstrate the utility of this bacterial
protein delivery system primarily because it is a DNA-interacting
protein which must localize to the nucleus to exert its recombinase
activity. Additionally, there are many Cre-dependent reporter cell
lines readily available, making this a very convenient assay system.
To determine the optimal signal sequence for delivery of the Cre,
we generatedfusionsof variouslengths ofExoS to Cre recombinase,
with the addition of a nuclear localization sequence in the fusion
junction (Fig. 2A). Each construct was then introduced into PAK-
JDSTY and tested for proper expression under type III inducing
condition as well as efficiency of T3SS mediated injection into host
cells. PAK-JDSTY strains containing the various fusion constructs
were grown in L-broth plus 5 mM EGTA for 3 hours to induce
type III secretion system genes. Cell pellets were separated on SDS-
PAGE and subjected to Western Blotting with an antibody against
Cre recombinase. As indicated in Figure 2B, all fusion proteins were
made equally, except for the full length ExoS fusion which was
produced at low level. Next, a human sarcoma cell line (TE26) was
infected with PAK-JDSTY containing the various length Cre
recombinase fusions at an MOI of 50 for 2 hours. As the injection
assay results show in Fig. 2C, while the first 17 amino acids of ExoS
appeartobe sufficient, 54aminoacidsdirected Crerecombinasefor
type III secretion more efficiently. Secretion was gradually reduced
as the ExoS portion increased beyond 54 amino acids long. To
verify that ExoS54-Cre injection occurs in a type III specific
manner, we also expressed this construct in a type III defective
strain,PAK-JDpopD [21],andsawnointracellularCrerecombinase
upon TE26 infection (Fig. 2C).
Functional analysis of bacterially delivered Cre protein
To assess the functionality of the fusion protein, we have
employed the TE26 cell line, which contains a floxed SV40
transcriptional terminator that prevents downstream lacZ expres-
sion (Fig. 3A). Upon Cre mediated recombination, the DNA
between loxP sites is removed, allowing lacZ expression which can
be evaluated by b-galactosidase activity.
TE26 cells were infected with PAK-JDSTY(pExoS54-Cre) at
various MOIs (20, 100, 500) for 1–3 hours. The infections were
cleared and cells were allowed 48 hours to undergo recombination
and lacZ expression. Cells were then fixed and stained with a
solution containingbromo-chloro-indolyl-galactopyranoside(X-gal)
to assess b-galactosidase activity. As the lacZ reporter gene contains
a nuclear localization sequence, the b-galactosidase activity was
mainly observed insidethe TE26 nuclei(Fig. 3B). The percentage of
b-galactosidase positive cells increases in a dose and time dependent
manner, with infectionat anMOIof500for3 hours resultinginthe
highest(42%)efficiency(Fig.3C).Theabilityofbacteriallydelivered
ExoS54-Cre to induce such levels of recombination indicates that
the process of type III secretion and the presence of the ExoS54
Figure 2. Injection of indicated ExoS-Cre fusions. (A)C r e
recombinase was fused in frame with various N-terminal portions of
ExoS, with a nuclear localization sequence (NLS) in the fusion junction.
(B) Detection of the five ExS54-Cre fusion proteins in PAK- JDSTY
harboring the corresponding fusion constructs. Bacterial cells were
grown under type III inducing condition and cell lysates were subjected
to Western blot using anti-Cre antibody. (C) TE26 cells were infected
with PAK-JDSTY containing the aforementioned constructs, lysed, and
subject to Western Blot with anti-Cre antibody. N, no infection control;
V, vector control, PAK-JDSTY/pUCP20; P, T3SS mutant control, PAK-
JDpopD/pExoS54-Cre; Lanes1-5 are Cre fusions to ExoS17, ExoS54,
ExoS96, ExoS234 and ExoS full length, respectively.
doi:10.1371/journal.pone.0016465.g002
Nuclear Protein Delivery into Mammalian Cells
PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e16465signal sequence interfere with neither the nuclear localization nor
the biological function of Cre recombinase.
Based on imunocytochemical staining of the translocated
proteins, nearly 100% of cells are normally injected by the
bacterially delivered proteins (Fig. 1B), however, the recombina-
tion efficiency is much lower than 100%. It is conceivable that
Cre-mediated DNA recombination can only occur when the target
loxP sites are freely accessible, most likely during the DNA
replication in S phase. Indeed, the maximal 42% LacZ positive
cells observed following infection of the TE26 cells correlated with
47% of S phase cells in the cell population, where G1/G0 and
G2/M phase cells were 34% and 19%, respectively, as determined
by FACS analysis of PI stained cells (Fig. 3D). To test this further,
TE26 cells were synchronized by a double thymidine blocking
method, obtaining cell population with 78% of the TE26 cells in S
phase while G1/G0 and G2/M phase cells were 17% and 5%,
respectively. Infection of the synchronized cells with the PAK-
JDSTY(pExoS-Cre) for 3 hours at an MOI 500 resulted in 75%
LacZ positive cells (Fig. 3D). Clearly, the proportion of lacZ
positive cells increases with the increased number of cells in S
phase, thus the Cre mediated recombination is significantly
influenced by the chromosome structure.
Delivery of functional nuclear proteins to mESC
Given the rise in the use of stem cells in many fields of biological
and pharmaceutical research, a proficient protein delivery system
should be applicable to both differentiated and pluripotent cells.
While the abilityof P.aeruginosa to infectan assortmentofcelltypes in
vitro has been well established, the susceptibility of pluripotent stem
cells to P. aeruginosa infection remains undetermined. In confirma-
tion, mESC were infected with PAK-JDSTY(pExoS-Flag), which
expresses a catalytically inactive, Flag-tagged version of ExoS.
Subsequent Western blot of the cell lysate illustrated clearly
translocated ExoS-Flag (Fig. 4A). The translocation occurred in a
type III secretion dependent manner as PAK-JDpopD(pExoS-Flag),
which is defective in type III secretion, was unable to deliver the
ExoS-Flag. These results are further substantiated by immunocyto-
chemical staining of PAK-JDSTY(pExoS-Flag) infected mESC with
an anti-Flag antibody (Fig. 4B). Together these data suggest that
mESC are also receptive to P. aeruginosa mediated protein delivery.
Considering the notorious difficulty of genetic manipulation in
stem cells, it is necessary to determine the ability of type III
secreted proteins to localize to the mESC nucleus and maintain
function. To quantitatively evaluate the functionality and
efficiency of protein delivery to mESC, we utilize a reporter cell
Figure 3. Assessment of Cre recombinase activity. Cre function was assessed by LacZ positive TE26 cells which contain a floxed terminator
preventing lacZ expression (A). TE26 cells were infected for various times and MOIs and subsequently stained with X-gal for b-galactosidase (B)t o
determine the optimal infection conditions as indicated by percentage LacZ positive cells (C). TE26 cells were infected at an MOI of 50 for 3 hours
before or after cell cycle synchronization and X-gal stained for b-galactosidase activity (D).
doi:10.1371/journal.pone.0016465.g003
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terminator preventing downstream expression of Enhanced
Yellow Fluorescent Protein (EYFP) in the Rosa26 locus (Fig. 4C)
[22]. Similar to the TE26 reporter, Cre mediated recombination
will allow for EYFP expression which can be visualized by
fluorescence microscopy and quantified by flow cytometric
analysis. R26R-EYFP mESC were co-incubated with PAK-
JDSTY(pExoS54-Cre) at various MOIs for 2.5 hours, as this
duration had been determined optimal in preliminary trials (data
not shown). Cells were subjected to FACS analysis 48 hours post-
infection. The efficacy of ExoS54-Cre mediated recombination is
represented as the percentage of EYFP positive cells in the infected
mESC population (Fig. 4D). Similar to the TE26 results, PAK-
JDSTY(pExoS54-Cre) induced recombination occurs in a type III
secretion specific, dose dependent manner (Fig. 4E). Recombina-
tion efficiency peaks with an MOI of 50, resulting in nearly 30%
EYFP positive cells, and steadily declines at higher MOIs, possibly
due to increased cytotoxicity. After sorting, EYFP positive cells
were plated on gelatin coated glass coverslips for observation of
EYFP expression as well as cellular morphology (Fig. 4F). The
ability of these previously infected cells to form colonies
characteristic of mESCs and maintain similar growth rate suggests
that neither bacterial infection nor bacterial protein mediated
alteration in gene expression have significant effects on the
pluripotency of these exceptionally sensitive cells.
Excision of reprogramming gene cassette from iPSC by
bacterially injected Cre protein
Induced pluripotent stem cells (iPSC) have been generated by
forced expression of four transcription factors Oct4, Sox2, c-Myc,
and Klf4, which are upregulated in embryonic stem cells [14].
Exogenous expression of these factors activates stable expression of
the endogenous pluripotency genes, relinquishing transgene depen-
dency [17]. While nuclear reprogramming is a breakthrough in the
field of stem cell biology, it is primarily criticized for the lingering
oncogenic transgenes that remain integrated in the chromosome of
iPSC. In order to circumvent this issue, a nuclear reprogramming
cassette was developed to contain all four transcriptional factors and a
mOrange fluorescent reporter flanked by loxP sites (Fig. 5A), such
that the cassette can be removed by Cre mediated recombination
following stable reprogramming. TNGim05 mouse embryonic
fibroblast derived iPSC were generated by integration of the single
reprogramming cassette, which has yet to be excised [17]. As such,
these cells display mESC-like morphology and mOrange expression
when cultured in vitro. Upon recombination, the reprogramming
cassette will be excised, and the iPSC will maintain pluripotency, but
lose mOrange expression.
The TNGim05 iPSC were infected at an MOI of 50 for 2.5 hours,
as this condition maximized ExoS54-Cre mediated recombination in
R26R-EYFP mESC (Fig. 4D). Cells were allowed 48 hours to
undergo recombination prior to FACS analysis. Sorted cells were
Figure 4. Protein injection into mouse embryonic stem cells (mESC). (A) mESC were infected with PAK-J strains at a MOI of 50 for 2.5 hours,
lysed and assayed for injected ExoS-Flag by anti-Flag Western Blot. (B) mESC were infected with PAK-JDSTY(pExoS-Flag) for 2.5 hours and
subsequently fixed and immunostained with anti-Flag to illuminate translocated ExoS-Flag protein. (C) R26R-EYFP mESC cells contain a floxed
terminator preventing downstream EYFP expression. (D) R26R-EYFP were infected with PAK-JDSTY(pExoS54-Cre) at various MOIs for 2.5 hours. Cells
were collected for FACS analysis 48 hours post infection. (E) EYFP-positive mESC were plated after infection to assess EYFP expression by confocal
fluorescence microscopy.
doi:10.1371/journal.pone.0016465.g004
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mOrange positive cells (Fig. 5B). While both infected and uninfected
TNGim05 iPSC samples contain an mOrange negative population,
there is a significant increase with PAK-JDSTY(pExoS54-Cre)
infection (Fig. 5C), indicating a subpopulation of the negative cells
have actually undergone recombination. Cassette excision was
verified by PCR analysis of pooled mOrange negative TNGim05
iPSC cells (Fig. 5D). In consistent with the fluorescence microscopic
imaging, PCR results demonstrate that while not the entire mOrange
negative population underwent recombination, there was a substan-
tial fraction of cells having had the reprogramming cassette removed
in an ExoS54-Cre dependent manner. Furthermore, the mOrange
negative cells propagated normally in ES medium, forming colonies
characteristics of iPS cells, suggesting transient exposure to the
bacteria did not alter the iPS cell characters.
Discussion
The use of the bacterial type III secretion system for transient
delivery of nuclear proteins to modify intrinsic gene expression has
the potential to replace many of the current methods that have
several pitfalls such as inefficient, mutagenic and clinically
inapplicable. To illustrate the utility of this system, we have
generated a strain of P. aeruginosa with diminished cytotoxicity to
deliver Cre, a well characterized protein which functions only in
the nucleus to interact with DNA and exerts its recombinase
activity. The availability of numerous Cre-dependent reporters has
conveniently allowed us to observe the effects of Cre delivery to
both differentiated and pluripotent cells. The ability of bacterially
delivered ExoS54-Cre to induce high levels of b-galactosidase
activity in TE26 cells indicates that the process of type III secretion
and the presence of the ExoS54 signal sequence do not interfere
with the ability of this protein to properly localize to the nucleus of
host cells or exert its biological function.
Our experimental data support the notion that Cre-mediated
DNA recombination can only occur when cells are in S phase or
when the target loxP sites are freely available, as evident from the
observation that the LacZ positive recombinant TE26 cells
increase in proportion to the S phase cells during the Cre delivery
by the bacteria. For TE26 cells, one full cell cycle takes around
34 hours to complete under our culture condition and a transition
time from G2 to S phase takes about 20 hours, thus to achieve
close to 100% efficiency of recombination, the injected Cre
protein needs to be stable for a time period when all of the cells go
through the S phase, which is at least 20 hours for TE26 cell.
Apparently, the intracellular stability of the injected ExoS54-Cre is
much shorter than the required 20 hours, presumably due to
proteasome mediated breakdown. It is possible to achieve 100%
Cre-mediated recombination by combining several approaches,
including (i) an increase of S-phase cell fraction by synchroniza-
tion, (ii) an increase of the half life of the translocated Cre by
utilizing a proteosome inhibitor, and (iii) successive infections for
Cre to encounter S phase for every cell in the population.
Figure 5. ExoS54-Cre mediated excision of an iPSC nuclear reprogramming cassette. TNGim05 iPSC contain a floxed reprogramming
cassette (A). ExoS54-Cre mediated recombination results in loss of mOrange expression, which can be observed by fluorescence confocal microscopy
(B) and flow cytometry (C). Reprogramming cassette excision is confirmed by PCR analysis (D). Lanes 1 and 3, IRES primer set, lanes 2 and 4, CAG
primer set.
doi:10.1371/journal.pone.0016465.g005
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presence of EYFP positive colonies after bacterial delivery of
ExoS54-Cre indicates that these cells are susceptible to P. aeruginosa
infection, but neither infection nor protein delivery significantly
affects the cellular morphology of R26R-EYFP mESCs. This
finding is in accordance with the results of a recent study which
demonstrates that mESC infection with other T3SS expressing
bacteria, such as Shigella flexneri, does not alter pluripotency, as
evaluated by Oct4 expression levels [23]. Given the inherent
difficulty of manipulating embryonic stem cells, we have achieved
relatively high delivery efficiency in a short time (2–3 hours) with a
single infection. The infection efficiency may further be increased
with multiple rounds of protein delivery. We are currently
investigating the proficiency of repeated protein delivery to modify
gene expression. In so doing, we are examining the long-term
effects of bacterial infection on host cell characters.
We observed a dose-dependent increase in the efficiency of
ExoS54-Cre-mediated recombination, which peaked around 30%
at a MOI of 50 for R26R-EYFP mESC. The subsequent decline in
recombination is clearly not due to insufficient protein delivery, but
more likely resultant of excess protein translocation or bacterial
cytotoxicity. Deletion of the P. aeruginosa type III secreted exotoxins
resulted in a considerable decrease in cytotoxicity, as compared to
that of wild-type PAK-J strain, which allowed cells to remain viable
and undergo gene expression changes after infection. However, P.
aeruginosa possesses additional virulence factors that contribute to
cytotoxicity. Efforts are currently underway to further reduce the
toxicity of this strain in an attempt to enhance cell viability and the
efficacy of protein delivery. In addition to reduction of cytotoxicity,
we are also in the process of engineering a strain which is more
sensitive to antibiotics. Currently, gentamicin and ciprofloxacin are
used to eradicate any residual bacteria after infection. While
bacterial survival assays have indicated that these conditions are
sufficient to destroy lingering intracellular and extracellular
bacteria, it will be more convenient to infect with a strain that is
sensitive to antibiotics commonly used in cell culture, such as
penicillin and streptomycin. Alternatively, an auxotrophic mutant
can also be utilized in which specific nutrient withdrawal will result
in inhibition of the bacterial growth.
These studies serve as a foundation for the bacterial delivery of
transcription factors to efficiently modulate concentration-depen-
dent and temporal activation of gene expression to direct cell fate
switch without jeopardizing genomic integrity which is critical for
future clinical translation. The ability of few exogenous transcrip-
tion factors to completely redirect endogenous gene expression is
epitomized by the discovery of nuclear reprogramming. Induction
of pluripotency, while almost exclusively achieved by transgene
expression, has been documented to occur with recombinant
protein transduction as well, albeit at extremely low efficiency
[24], [25]. Having demonstrated the ability to deliver large
quantities of nuclear targeting protein directly into eukaryotic
cells, efforts are currently underway to harness the power of
the type III secretion system to deliver nuclear reprogramming
factors to efficiently induce pluripotency and lineage specific
differentiation.
Materials and Methods
Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are listed in
Table 1. P. aeruginosa and E. coli were grown in Luria (L) broth or
on L agar plates at 37uC. Antibiotics were used at a final
concentration of 150 mg carbenicillin, or 100 mg tetracycline per
ml for P. aeruginosa and 100 mg ampicillin per ml for E. coli.
Table 1. Strains and plasmids used in this study.
Strain or plasmid Description Source
P. aeruginosa
PAO1 P. aeruginosa laboratory strain [30]
PAK P. aeruginosa laboratory strain David Bradley
PAK-J PAK derivative with enhanced T3SS This study
PAK-JDpopD PAK with chromosomal deletion of the popD locus This study
PAK-JDSTY PAK with chromosomal deletion of exoS, exoT, exoY loci This study
E. coli
S-17 Strain expressing DNA mobilization genes [31]
DH5a F
2 w80DlacZDM15 endA1 recA1 hsdR17(mk-mk-) supE44 thi-1 relA1 D(lacZYA-argF) gyrA96 deoR [32]
Plasmids
pUCP20 Escherichia-Pseudomonas shuttle vector; Ap
r (Cb
r) [33]
pExoS17-Cre 17 aa of ExoS fused to nuclear Cre recombinase in pUCP20; Cb
r This Study
pExoS54-Cre 54 aa of ExoS fused to nuclear Cre recombinase in pUCP20; Cb
r This Study
pExoS96-Cre 96 aa of ExoS fused to nuclear Cre recombinase in pUCP20; Cb
r This Study
pExoS234-Cre 234 aa of ExoS fused to nuclear Cre recombinase in pUCP20; Cb
r This Study
pExoS-Flag pHW0224, pUCP18 containing catalytically inactive ExoS with a Flag tag; Cb
r [34]
pExoS54 N-terminal 54 aa of ExoS in pUCP20; Cb
r This study
pEX18Tc Vector containing sacB and Tc
r for exconjugant selection [35]
pEX18Tc-DS pEX18Tc containing 1 kb regions up and downstream of exoS;T c
r This Study
pEX18Tc-DT pEX18Tc containing 1 kb regions up and downstream of exoT;T c
r This Study
pEX18Tc-DY pEX18Tc containing 1 kb regions up and downstream of exoY;T c
r This Study
doi:10.1371/journal.pone.0016465.t001
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PCR amplification of successive lengths of the 59 region of exoS,
using primers listed in Table 2. Each primer contains 59 restriction
endonuclease sites (EcoRI or SacI) for convenient cloning. The
nuclear Cre recombinase gene was amplified to include an SV40
large T antigen nuclear localization sequence [26] using the
primers listed in Table 2. Cre recombinase and a variable portion
of exoS were cloned into pUCP20 in a triple ligation using EcoRI,
SacI and SalI restriction sites. Constructs were confirmed by
restriction analysis and DNA sequencing. P. aeruginosa PAK-JDSTY
was generated by successive unmarked allelic exchange, as
previously described [27].
Cell Culture
TE26 cells, a single cell clone carrying floxed nuclear lacZ
reporter gene derived from human rhabdomyossarcoma cell line
TE671 (ATCC CRL08805), were grown in Dulbecco’s Modified
Eagle Medium (DMEM; Gibco) supplemented with 15% Fetal
Bovine Serum (FBS) [28]. R26R-EYFP mouse embryonic stem
cells (mESC) [27] and TNGim05 induced pluripotent stem cells
(iPSC) [17], were grown on 0.1% gelatin (Millipore) coated plates
in mESC media [29]. All cells were cultured at 37uC with 5%
CO2, and supplemented with Penicillin, Streptomycin, and
Amphotericin (Cellgro). Gentamicin and Ciprofloxacin were
added at final concentrations of 200 mg and 20 mg per ml,
respectively, where noted.
Protein injection assay
Mammalian cells were plated at approximately 60% confluency
in antibiotic-free media the night before infection. P. aeruginosa was
grown at 37uC in L broth containing carbenicillin until reaching
OD600 of 0.8. Cells were infected with 0.5610
8 cfu P. aeruginosa
per ml of growth media for a multiplicity of infection (MOI) of 50.
Cells were co-incubated with P. aeruginosa for 3 hours in DMEM
containing 5% FBS, unless otherwise stated. Infections were
cleared by removing the media and washing cells 3 times in PBS,
and adding media containing gentamicin and ciprofloxacin.
For Western Blot analysis of translocated proteins, cells were
collected immediately following infection by incubation with
0.25% Trypsin for 5 minutes. The suspension was centrifuged
for 5 minutes at 500 xg. Cells were washed in PBS, and
centrifuged for 5 minutes at 500 xg. The cell pellets were lysed
in 40 ml PBS containing 0.25% Triton-X on ice for 10 minutes.
The lysed cells were then centrifuged at 16,000 xg for 5 minutes.
The soluble fraction was collected, mixed with an equal volume of
2x SDS-PAGE loading buffer and boiled for 10 minutes.
Following separation on 12% SDS-PAGE and transferred to
PVDF, The blots were probed with antibodies against ExoS
(rabbit polyclonal), Cre recombinase (mouse monoclonal, Abcam),
or Flag (mouse M2 monoclonal Ab, Sigma).
Immunocytochemistry
Cells were fixed in 3.7% formaldehyde in PBS for 15 minutes at
room temperature. Cells were then washed 3x in PBS and
permeablized in 0.5% Triton X-100 in PBS. Cells were then
washed 3x in PBST and blocked with 1% BSA in PBST for 30
minutes. Cells were incubated with primary antibodies for 2 hours
at room temperature, then washed 3x in PBST. Cells were
incubated with the secondary antibody for 1 hour at room
temperature, then washed 3x in PBST and examined under
fluorescence microscope.
Cytotoxicity assays
Cells were infected by P. aeruginosa for 1, 2, or 3 hours as
described above. After infection, the cells were washed and
incubated with 0.25% Trypsin for 5 minutes. The number of cells
Table 2. PCR primers used in this study.
For ExoS-Cre fusions
ExoS- upstream 59-GACGAATTCGGCGTCTTCCGAGTCACTGGAGGC-39
ExoS17 downstream 59-GACGAGTCGTGCAATTCGACGGCGAAAGACGG-39
ExoS54 downstream 59-GAGCTCGAGCAGCCCCTCACCCTTCGGCGCGTCC-39
ExoS96 downstream 59-GACGAGCTCGGACATCAGCGCAGGCTGCGCGTC-39
ExoS129 downstream 59-GACGAGCTCTTCCGGTGTCAGGGTCGCCAGCTC-39
ExoS234 downstream 59-GACGAGCTCCTTGTCGGCCGATACTCTGCTGAC-39
ExoS full downstream 59-GACGAGCTCGGCCAGATCAAGGCCGCGCATCCT-39
Cre upstream 59-GGAGCTCATGCCTAAGAAGAAACGAAAGATC-39
Cre downstream 59-CGAGGTCGACGGTATCGATAAGCTTG-39
For exoS, exoT and exoY deletion 59 and 39 PCR primer sets
ExoS upstream
(EcoR1-BglII)
59-CAAGGAATTCGGATTATGCGGAGGGGTTGCCGGTG-39
59-GTTGAGATCTCCTGATGTTTCTCCGCCAGTCTAGGAA-39
ExoS downstream
(BglII-HindIII)
59-GTCCAGATCTTGGCTCGGCAGCGGATCCGGGTGGAG-39
59-TGGAAAGCTTCGTCATCCTCAATCCGTACGGCAGGC-39
ExoT upstream
(EcoR1-BamH1)
59-GGAGGAATTCGAAGGGGTTGCGCAGGCCTGGCTCGTC-39
59-TGACGGATCCTGATGTTTCCCCGCCAGTCTAGGAACG-39
ExoT downstream
(BamH1-HindIII)
59-CGGAGGATCCCAAGGGGTGTCCGTTTTCATTTGCGCC-39
59-AGGTAAGCTTCCAGCGCCTGCGCCTGGGCCTCCTTG-39
ExoY upstream
(EcoR1-BamH1)
59-AACTGAATTCCGAGGATGTCGCCCTGCTCGACCATCGGG-39
59-CCCAGGATCCAGGAGGCGCTCGACTTTTTCCAACGTA-39
ExoY downstream
(BamH1-HindIII)
59-ATAAGGATCCGGGCAGCGGCGAGATATCAGAAAACG-39
59-CGTTAAGCTTGAGATAGCCGAGCATGCTCAGGCCGTC-39
doi:10.1371/journal.pone.0016465.t002
Nuclear Protein Delivery into Mammalian Cells
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16465were then counted under microscope. The LDH release assay used
CytoTox96 (Promega) and followed the manufacturer’s instruc-
tion.
b-galactosidase assays
TE26 cells were stained for b-galactosidase activity 48 hours
after P. aeruginosa infection. Cells were fixed in 1% formaldehyde
and 0.2% gluteraldehyde in PBS for 5 minutes and stained in a
solution containing 4 mM K4Fe(CN)6, 4 mM K3Fe(CN)6,2m M
MgCl2 and 0.4 mg/ml X-gal for 24 hours at 37uC. Percent b-
galactosidase positive cells were determined by visual counts of
blue and white cells under a light microscope.
Flow cytometry
Infected cells were collected by 0.25% Trypsin treatment
48 hours after P. aeruginosa infection. Cells were centrifuged at
500 xg for 5 minutes and resuspended in 0.5 ml PBS containing
2% FBS. Cells were analyzed for EYFP or mOrange expression
using Diva v6.2 on LSR-II (BD-Biosciences) and FACS Aria II
(BD-Biosciences) for flow cytometry.
Cell synchronization
TE26 cells grown in DMEM containing 15% FBS were
cultured for 2 days and then incubated in medium containing
2 mM thymidine for 18 hours. Cells were then washed twice with
PBS, and incubated with regular DMEM for 9 hours before a
second incubation in 2 mM thymidine for 17 hours. At 0, 2, 5, 6,
9, 12, 16 and 24 hours after release from the second thymidine
block, cell-cycle phase distribution was analyzed by flow cytometry
with propidium iodide (PI) staining to verify the synchrony. Briefly,
cells were fixed with ice-cold 70% ethanol for 24 h, then
centrifuged and the cell pellet resuspended in 0.4 ml of PBS,
50 ml of RNase A (10 mg/ml) and 10 ml of PI (2 mg/ml). The
mixture was incubated in the dark at 37uC for 30 min and then
analyzed by FACsort flow cytometer (Becton Dickinson).
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